Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-10-20
1989-04-18
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514346, 546291, 546294, C07D21374, C07D21375, A61K 3144
Patent
active
048228079
ABSTRACT:
The present invention provides a process for the preparation of cystalline torasemide in the pure modification I (monoclinic, space group P2.sub.1 /c, melting point 162.degree. C.) from torasemide of modification II (monoclinic, space group P2
, melting point 169.degree. C.), wherein a suspension of torasemide of modification II is stirred in water with the addition of a catalytic amount of modification I until the rearrangement is complete.
The present invention also provides pharmaceutical compositions containing torasemide of modification I.
REFERENCES:
patent: Re30633 (1977-04-01), DeLarge et al.
patent: 4018929 (1977-04-01), DeLarge et al.
Chem. Abstracts, vol. 92(15), abst. no. 128,739e, Apr. 14, 1980.
Chem. Abstracts, vol. 95(25), abst. no. 214,829n, Dec. 21, 1981.
Chem. Abstracts, vol. 97(21), abst. no. 174,700w, Nov. 22, 1982.
REMINGTONS' PHARMACEUTICAL SCIENCES, Fourteenth Edition, pp. 140-142, 170, 208-221, Mack Publishing Co., (1970).
Dupont et al., "Structure Cristalline et Moleculaire dun Divretigue . . . ", Acta Cryst. B34, 1304-1310, (1978).
Dupont et al., "Structure dune Seconde Variete de la Torasemide", Acta Cryst. B34, 2659-2662, (1978).
Lettenbauer Gustav
Topfmeier Fritz
Boehringer Mannheim GmbH
Rotman Alan L.
LandOfFree
Pharmaceutical composition containing a stable modification of t does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition containing a stable modification of t, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition containing a stable modification of t will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2397178